10-Q: Henry Schein Reports Mixed Q2 Results Amid Cyber Incident Recovery
Quarterly Report
Henry Schein's second-quarter results show a slight sales increase but are impacted by the ongoing recovery from a cyber incident and restructuring efforts.
Summary
- Henry Schein's net sales for the second quarter of 2024 increased by 1.1% to $3.136 billion compared to $3.100 billion in the same period last year.
- The company's health care distribution segment saw a modest increase in sales, while technology and value-added services experienced a 10.8% growth.
- The cyber incident from October 2023 continued to impact sales, particularly to episodic customers, with a residual effect on the company's North American and European dental and medical distribution businesses.
- Restructuring costs were $15 million for the quarter and $25 million for the six months ended June 29, 2024, primarily related to severance and employee-related costs, accelerated amortization, and lease exit costs.
- The company's operating income decreased to $159 million from $201 million in the prior year's quarter.
- Net income attributable to Henry Schein, Inc. was $104 million, down from $140 million in the same quarter of the previous year.
- The company received $10 million in insurance proceeds related to the cyber incident, which partially offset the expenses incurred.
- The effective tax rate for the six months ended June 29, 2024, was 25.2%, compared to 22.8% for the prior year period.
Sentiment
Score: 5
Explanation: The sentiment is neutral to slightly negative due to the mixed results, ongoing challenges from the cyber incident, and decreased profitability, offset by some positive growth in specific segments and the insurance recovery.
Positives
- The technology and value-added services segment showed strong growth with a 10.8% increase in net sales.
- The company received $10 million in insurance proceeds related to the cyber incident, partially offsetting related expenses.
- The company is actively working to re-establish relationships with episodic customers affected by the cyber incident.
- The company's medical business saw a 5.0% increase in net sales for the quarter and 6.2% for the six months ended June 29, 2024.
- The company's gross profit increased by 4.4% for the quarter and 4.6% for the six months ended June 29, 2024.
Negatives
- The cyber incident from October 2023 continues to negatively impact sales, particularly to episodic customers.
- Operating income decreased to $159 million in Q2 2024 from $201 million in the prior year's quarter.
- Net income attributable to Henry Schein, Inc. decreased to $104 million in Q2 2024 from $140 million in the same quarter of the previous year.
- The company incurred $3 million in expenses directly related to the cyber incident in Q2 2024.
- The company's internally generated local currency sales decreased by 2.4% for the quarter and 2.1% for the six months ended June 29, 2024.
- The company's dental business saw a 1.7% decrease in net sales for the quarter and 0.5% for the six months ended June 29, 2024.
Risks
- The ongoing recovery from the cyber incident poses a risk to future sales, particularly with episodic customers.
- The company faces challenges in re-establishing customer relationships and regaining lost sales.
- The company's financial performance is subject to the impact of economic conditions and market fluctuations.
- The company is subject to various legal proceedings, including opioid-related lawsuits and a class action related to the cyber incident.
- The company's effective tax rate may be impacted by future tax reforms.
- The company's ability to generate sufficient cash flows from operations is dependent on the continued demand of our customers for our products and services, and access to products and services from our suppliers.
Future Outlook
The company expects to record restructuring charges of $12 million related to the 2022 Plan during the remainder of 2024 and expects to record restructuring charges associated with the 2024 Plan during the second half of 2024 and in 2025, however an estimate of the amount of these charges has not yet been determined. The company also plans to accelerate its share repurchase activity in light of its favorable cash position.
Management Comments
- The company is focused on re-establishing relationships with episodic customers affected by the cyber incident.
- The company is actively working to integrate recent acquisitions and streamline operations.
- The company believes that its cash and cash equivalents, its ability to access private debt markets and public equity markets, and its available funds under existing credit facilities provide it with sufficient liquidity to meet its currently foreseeable short-term and long-term capital needs.
Industry Context
The health care industry is experiencing ongoing consolidation and a focus on cost containment, which benefits distributors capable of providing a broad array of products and services at low prices. The aging population and increased health care awareness are also driving growth in the industry. The company is positioned to capitalize on these trends through its broad product and service offerings and strategic acquisitions.
Comparison to Industry Standards
- Henry Schein's performance is mixed when compared to industry standards. While the technology and value-added services segment shows strong growth, the healthcare distribution segment is facing challenges due to the cyber incident and economic conditions.
- Competitors in the healthcare distribution space, such as McKesson and Cardinal Health, have also reported varying results, with some experiencing similar challenges related to supply chain and economic pressures.
- The company's gross margin of 32.5% is within the typical range for healthcare distributors, but the technology segment's higher margins are a key differentiator.
- The company's debt levels are comparable to other large distributors, but the company's ability to manage its debt and maintain liquidity will be critical in the coming quarters.
- The company's restructuring efforts are similar to those undertaken by other companies in the industry to improve efficiency and profitability.
Legal Proceedings
- Henry Schein, Inc. is a defendant in multiple opioid-related lawsuits.
- The company received a Grand Jury Subpoena from the United States Attorneys Office for the Western District of Virginia related to a former subsidiary.
- A class action lawsuit was filed against the company in the U.S. District Court for the Eastern District of New York (EDNY) based on the October 2023 cyber incident.
- Henry Schein, Inc. and its subsidiary, North American Rescue, LLC (NAR), were named as defendants in a qui tam lawsuit brought under the federal False Claims Act (FCA).
Related Party Transactions
- The company has a royalty agreement with Internet Brands, where it pays approximately $31 million annually for the use of their intellectual property.
- The company recorded net sales of $12 million and $24 million respectively, to entities accounted for under the equity accounting method during the three and six months ended June 29, 2024.
- The company purchased $2 million and $5 million respectively, from such entities during the three and six months ended June 29, 2024.
- Certain facilities related to acquisitions are leased from employees and minority shareholders.
Stakeholder Impact
- Shareholders may be concerned about the decreased profitability and the ongoing impact of the cyber incident.
- Employees may be affected by the restructuring plans, which include potential severance and employee-related costs.
- Customers may experience disruptions due to the cyber incident and the company's efforts to re-establish relationships.
- Suppliers may be impacted by changes in the company's purchasing patterns and restructuring efforts.
- Creditors may be affected by the company's debt levels and its ability to generate sufficient cash flows.
Next Steps
- The company will continue to focus on re-establishing relationships with episodic customers.
- The company will continue to integrate recent acquisitions and streamline operations.
- The company will implement the new restructuring plan (the 2024 Plan) to further increase efficiencies.
- The company plans to accelerate its share repurchase activity.
- The company will continue to monitor and manage the impact of the cyber incident.
Key Dates
| Date | Description |
|---|---|
| December 24, 2012 | Date of a private placement facility borrowing. |
| June 16, 2017 | Date of a private placement facility borrowing. |
| September 15, 2017 | Date of a private placement facility borrowing. |
| January 2, 2018 | Date of a private placement facility borrowing. |
| September 2, 2020 | Date of a private placement facility borrowing. |
| August 20, 2021 | Date of the original revolving credit agreement. |
| June 2, 2021 | Date of a private placement facility borrowing. |
| May 4, 2023 | Date of multiple private placement facility borrowings. |
| April 5, 2023 | Date of the acquisition of Biotech Dental. |
| July 5, 2023 | Date of the acquisition of S.I.N. Implant System. |
| July 11, 2023 | Date of the amended and restated revolving credit agreement and the term loan credit agreement. |
| October 2, 2023 | Date of the acquisition of Shield Healthcare. |
| October 2023 | Date of the cyber incident. |
| November 22, 2023 | Date of the disruption of the ecommerce platform. |
| January 18, 2024 | Date a class action was filed against the company in the U.S. District Court for the Eastern District of New York (EDNY). |
| April 1, 2024 | Date of the acquisition of TriMed Inc. |
| May 17, 2024 | Date of the amendment to the U.S. trade accounts receivable securitization facility. |
| June 6, 2024 | Date plaintiffs and the company informed the court that they had agreed to a term sheet for a class action settlement. |
| June 29, 2024 | End of the quarterly period. |
| July 11, 2028 | Maturity date of the revolving credit agreement. |
| July 31, 2024 | Date the 2022 restructuring plan was completed and the board authorized an additional $500 million in share repurchases. |
| August 6, 2024 | Date the company committed to a new restructuring plan (the 2024 Plan). |
| September 13, 2024 | Date the court ordered plaintiffs to move for preliminary approval of the proposed settlement. |
| December 15, 2025 | Expiration date of the U.S. trade accounts receivable securitization facility. |
| October 20, 2026 | End date of the private placement facilities. |
| July 11, 2026 | Maturity date of the term loan credit agreement. |
Keywords
cyber incident, healthcare distribution, technology services, dental, medical, restructuring, net sales, operating income, net income, acquisitions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.